New blood test could help monitor T-Cell lymphoma
NCT ID NCT06362148
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a new blood test can find tiny bits of tumor DNA in people with T-cell lymphoma. The goal is to see if this test can help doctors track how well treatment is working and watch for signs of the cancer coming back. About 50 adults with newly diagnosed or returning lymphoma will give blood samples over two years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NK/T-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Hematology, Aarhus University Hospital
Aarhus, Central Jutland, 8200, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple blood test spot lymphoma earlier?
- Can a Five-Drug combo tame a tough lymphoma without standard chemo?
- Can a targeted pill boost Chemotherapy's punch against a rare lymphoma?
- A microchip implanted in tumors could reveal which drugs work best
- Can a cancer drug reboot the immune system after a stem cell transplant?
- Experimental drug combo aims to tackle tough lymphoma